Bio-Rad Labs (BIO) Misses Q3 EPS by 46c
Tweet
Share
E-mailGet Alerts BIO Hot Sheet
Price: $285.94 -2.22%
Revenue Growth %: -4.3%
Financial Fact:
Research and development expense: 52.17M
Today's EPS Names:
PLCE, COE, JVA, More
Revenue Growth %: -4.3%
Financial Fact:
Research and development expense: 52.17M
Today's EPS Names:
PLCE, COE, JVA, More
Join SI Premium – FREE
Bio-Rad Labs (NYSE: BIO) reported Q3 EPS of $0.40, $0.46 worse than the analyst estimate of $0.86. Revenue for the quarter came in at $530.6 million versus the consensus estimate of $525.4 million.
For earnings history and earnings-related data on Bio-Rad Labs (BIO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Nvidia pitches Vera CPU to Chinese clients with August delivery target
- MIND Technology (MIND) Misses Q1 EPS by 5c
- United Community Banks sells equipment finance unit for $1.9 billion
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
